ALM.D News
About
Almirall S.A. Right represents a type of derivative security issued in connection with Almirall S.A., a global biopharmaceutical company headquartered in Barcelona. As a right, this financial instrument typically grants shareholders a time-limited privilege to purchase additional ordinary shares of Almirall S.A., often at a set price and in proportion to their existing holdings. These rights are commonly distributed during capital-raising events, such as rights issues, enabling the company to attract fresh equity capital while offering current shareholders the opportunity to maintain or increase their ownership percentage. Almirall S.A. is recognized for its focus on medical dermatology and skin health, with a broad presence across Europe, the United States, and other markets. The issuance of rights by Almirall S.A. underscores its active approach to capital management and shareholder engagement, serving as an important mechanism for financing strategic growth or research initiatives within the pharmaceutical sector.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance